We first tested the ability of TcdBFBD to inhibit Wnt signaling in a human triple-negative breast cancer cell line MDA-MB-231 using a well-established TOPFLASH/TK-Renilla dual luciferase reporter assay. The gene discussed is TKT; the disease is triple-negative breast carcinoma.